Oracle Investment Management Inc. Sells 19,964 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Oracle Investment Management Inc. reduced its holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 3.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 535,558 shares of the biotechnology company’s stock after selling 19,964 shares during the period. […]

Related Keywords

Alang Levin ,Stevenk Galson , ,Exchange Commission ,Securities Exchange Commission ,News Ratings For Biocryst Pharmaceuticals Daily ,Quarter For Biocryst Pharmaceuticals ,Deerfield Management Companylp Series ,Vanguard Group Inc ,Nasdaq ,Needham Company ,Oracle Investment Management Inc ,Rafferty Asset Management ,Norges Bank ,Biocryst Pharmaceuticals ,Biocryst Pharmaceuticals Price Performance ,Biocryst Pharmaceuticals Inc ,Oracle Investment Management ,Free Report ,Cryst Pharmaceuticals ,Investment Management ,Asset Management ,Director Alan ,Director Steven ,Get Free Report ,Visit Holdingschannel ,Biocryst Pharmaceuticals Daily ,